Table 8.
Main characteristics of the studies included in the review of other system tumors
| Study | Tumor types | Sample size (Normal: Tumor) |
Detection Method | P value | TNM (p value) |
LNM (p value) |
DM (p value) |
OS (p value) |
References |
|---|---|---|---|---|---|---|---|---|---|
| Li | Osteosarcoma | (145: 145) | qRT-PCR | p < 0.01 | p = 0.007 | / | p = 0.008 | p < 0.001 | Li et al. 2017) |
| Xu | Osteosarcoma | (66: 66) | qRT-PCR | p < 0.01 | / | / | / | / | Xu et al. 2017) |
| Wang | Osteosarcoma | (64: 64) | qRT-PCR | p < 0.01 | / | / | p = 0.012 | p = 0.034 | Wang et al. 2019) |
| Li | Osteosarcoma | (35: 35) | qRT-PCR | p < 0.01 | / | / | / | / | Li et al. 2019b) |
| Lv | Osteosarcoma | (34: 34) | qRT-PCR | p < 0.05 | / | / | / | / | Lv et al. 2018) |
| Wen | Osteosarcoma | (30: 30) | qRT-PCR | p < 0.001 | / | / | / | / | Wen et al. 2020) |
| Hai | Osteosarcoma | (15: 38) | qRT-PCR | p < 0.001 | / | / | / | p = 0.0221 | Hai et al. 2021) |
| Zhou | Bladder cancer | (52: 52) | qRT-PCR | p < 0.01 | p = 0.001 | p = 0.001 | p = 0.001 | p = 0.039 | Zhou et al. 2019) |
| Xiong | Bladder cancer | (67: 67) | qRT-PCR | p < 0.01 | p = 0.01 | / | / | / | Xiong et al. 2017) |
| Hu | Bladder cancer | (52: 52) | qRT-PCR | p < 0.05 | p = 0.012 | p = 0.042 | / | p = 0.0332 | Hu et al. 2017) |
| Xu | Retinoblastoma | (53: 87) | qRT-PCR | p < 0.05 | / | / | / | p < 0.05 | Xu and Tian 2020) |
| Hu | Retinoblastoma | (6: 30) | qRT-PCR | p < 0.01 | p < 0.01 | / | / | / | Hu et al. 2018) |
| Cheng | Retinoblastoma | (7: 53) | qRT-PCR | p < 0.05 | / | / | / | / | Cheng et al. 2019) |
| Wang | Retinoblastoma | (8: 20) | qRT-PCR | p < 0.001 | / | / | / | / | Wang et al. 2020d) |
| Zhao | Retinoblastoma | (54: 54) | qRT-PCR | p < 0.001 | / | / | / | / | Zhao et al. 2020) |
| Yang | Retinoblastoma | (30: 30) | qRT-PCR | p < 0.05 | / | / | / | / | Yang et al. 2020) |
| Yao | Retinoblastoma | (6: 25) | qRT-PCR | p < 0.05 | / | / | / | / | Yao et al. 2020) |
| Zhu | Cervical cancer | (52: 52) | qRT-PCR | p < 0.01 | p = 0.04 | / | p = 0.027 | p = 0.015 | Zhu et al. 2018a) |
| Chen | Cervical cancer | (30: 30) | qRT-PCR | p < 0.001 | p = 0.033 | p = 0.038 | / | / | Chen et al. 2019b) |
| Liu | Cervical cancer | (35: 35) | qRT-PCR | p < 0.05 | p < 0.05 | / | / | p < 0.01 | Liu et al. 2020) |
| Xu | Thyroid cancer | (36: 36) | qRT-PCR | p < 0.01 | p < 0.01 | p < 0.01 | / | / | Xu et al. 2018b) |
| Liu | Thyroid cancer | (77: 77) | qRT-PCR | p < 0.01 | / | / | / | p = 0.025 | Liu et al. 2018) |
| Du | Thyroid cancer | (24: 24) | qRT-PCR | p < 0.01 | / | / | / | / | Du et al. 2021) |
| Song | Nasopharyngeal cancer | (108: 108) | qRT-PCR | p < 0.05 | / | / | / | p = 0.0005 | Song et al. 2016) |
| Cheng | Nasopharyngeal cancer | (10: 20) | qRT-PCR | p < 0.05 | / | / | / | / | Cheng et al. 2018) |
| Shi | Nasopharyngeal cancer | (40: 40) | qRT-PCR | p < 0.05 | / | / | / | / | Shi et al. 2020) |
| Zhao | Nasopharyngeal cancer | (25: 25) | qRT-PCR | p < 0.05 | / | / | / | / | Zhao et al. 2020) |
| Hao | Melanoma | (15: 15) | qRT-PCR | p < 0.01 | / | / | / | / | Hao et al. 2021) |
| Wang | Leukemia | (20: 62) | qRT-PCR | p < 0.05 | / | / | / | / | Wang et al. 2020a) |